Iron uptake by transferrin from triacetohydroxamatoFe(III) (Fe(AHA) 3 ) in the presence of bicarbonate has been investigated between pH 7 and 8.2. The protein transits from the opened apo-to the closed holoform by several steps with the accumulation of at least three kinetic intermediates. All these steps are accompanied by proton losses, probably occurring from the protein ligands and the side-chains involved in the interdomain H-bonding nets. The minor bihydroxamatoFe(III) species Fe(AHA) 2 exchanges its iron with the C-site of apotransferrin in interaction with bicarbonate without detectable formation of any intermediate protein-iron-ligand mixed complex; direct second-order rate constant k 1 4.15(AE0.05) Â 10 7 M À1 s À1 . The kinetic product loses a single proton and undergoes a modi®cation in its conformation followed by the loss of two or three protons; ®rst-order rate constant k 2 3.25(AE0.15) s À1 . This induces a new modi®cation in the conformation; ®rst-order rate constant k 3 5.90(AE0.30) Â 10 À2 s À1 . This new modi®cation in conformation rate controls iron uptake by the N-site of the protein and is followed by a single proton loss; K 3a 6.80 nM. Finally, the holoprotein or the monoferric transferrin in its thermodynamic equilibrated state is produced by a last modi®cation in the conformation occurring in about 4000 seconds. But for the Fe(AHA) 3 dissociation and the involvement of Fe(AHA) 2 in the ®rst step of iron uptake, this mechanism is identical to that reported for iron uptake from FeNAc 3 . This implies that the exchange of iron between a chelate and serum-transferrin occurs by a single general mechanism. The nature of the iron-providing chelate is only important for the ®rst kinetic step of the exchange, which can be slowed to such an extent that it rate limits the exchange of iron.
Introduction
The transferrin family constitutes the major iron transport and/or scavenging system in vertebrates and some invertebrates (Aisen, 1998) . Most of the transferrins are soluble glycoproteins which consist of a single chain of about 700 amino acid residues and 80 kDa (Aisen, 1998) . They are bilobal and E-mail address of the corresponding author: chahine@paris7.jussieu.fr Abbreviations used: FeNAc 3 , nitrilotriacetatoiron(III); Fe(AHA) 3 , triacetohydroxamatoiron(III); FeL, FeL 2 and FeL 3 the different chelates; L, chelating ligand; T H c H 2 the C-site of apotransferrin in neutral media and in the absence of carbonate with two protein ligands in the protonated form; T C H 3 , the C-site of apotransferrin interacting with bicarbonate; T C H 3 Fe and T C H 2 Fe, the ®rst protein-iron intermediate in the protonated and deprotonated forms; H 3 T N T C H 2 Fe, TH 5 Fe, TH (5Àm) Fe each lobe is organised to form a metal binding cleft or pocket in which iron is co-ordinated to four protein ligands and a synergistic carbonate anion (Jeffrey et al., 1998; Moore et al., 1997; Kurokawa et al., 1995; Zuccola, 1992) .
Serum-transferrins and ovotransferrins transport iron from neutral biological¯uids to the cytoplasm by receptor-mediated endocytosis (Dautry Varsat et al., 1983) . In contrast, lactoferrins and again ovotransferrins behave as bacteriostatic iron scavengers (Moore et al., 1997; Kurokawa et al., 1995) . In a recent series of articles, we investigated the kinetics and thermodynamics of iron uptake from nitrilotriacetatoFe(III) (FeNAc 3 ), by these three major iron transport and sequestration transferrins: serumtransferrin (Mechanism I), lactoferrin and ovotransferrin. We showed that iron uptake occurs by similar mechanisms with the three proteins with, however, important differences in the rates and in the number of protons lost during the uptake (El Hage Chahine & Fain, 1993; Pakdaman et al., 1998; Bou Abdallah & El Hage Chahine, 1998) .
Mechanism I
The ®rst step in iron uptake by serum-transferrin is the exchange of Fe(III) between the low molecular mass chelate FeNAc 3 , and the C-site of the protein in interaction with bicarbonate (T C H 3 ) to yield (T C H 3 Fe) a ®rst C-site iron-loaded protein (equations (1) and (2) (6)) followed by a new proton loss (T H H (4 À m) Fe, equation (7)) allow the N-site to capture a Fe(III) cation if it is available in the medium (equation (8)). It also allows the protein, whether monoferric or diferric, to attain its ®nal state of equilibrium in a ®nal conformation change which lasts about 4000 seconds at 25
Fe 2 , equations (9) and (10); .
In Mechanism I, iron exchange between FeNAc 3 and serum-transferrin occurs without the accumulation of any mixed protein-FeNAc 3 ternary intermediate complex. However, according to Bates and co-workers, transferrin interacts with the low molecular mass chelate (FeL) to yield an intermediate ternary complex (TFeL) which in turn loses L, the chelating agent (Mechanism II, equations (11) and (12); Bates et al., 1967; Bates & Wernicke, 1971; Bates & Schlabach, 1975; Cowart et al., 1982 Cowart et al., , 1986 .
Mechanism II
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Kinetic intermediates were detected during iron uptake from the acetohydroxamic acid and pyrophosphate complexes and were assumed to be the ternary intermediates TFeL (Cowart et al., 1982 (Cowart et al., , 1986 . Iron release from holotransferrin was presumed promoted by anion binding to the protein and considered as possibly occurring by two different paths: (i) via the ternary intermediate (equations (11) and (12)); and/or (ii) without the involvement of this intermediate (equation (13); Egan et al., 1992) . Before being targeted for degradation, a serumtransferrin molecule performs about 100 cycles of iron-delivery by endocytosis (Dautry-Varsat et al., 1983; Crichton, 1991) . Therefore, during its lifetime a serum-transferrin molecule interacts with iron about 100 times. Iron(III) is completely insoluble in neutral media where it can only exist in the complex form (Hancock & Martell, 1989) . In order to be iron loaded, transferrins or any other iron transport systems such as siderophores are constrained to extract iron from a soluble complex (Crichton, 1991) . We, therefore, believe that the understanding of the general mechanism of formation of a complex between iron(III) in vitro and transferrins is of importance for the comprehension of the metabolic role of these proteins in regulating iron in vivo.
Here we use the methods and techniques of chemical relaxation to re-examine iron uptake from triacetohydroxamatoiron(III), Fe(AHA) 3 , by serumtransferrin.
Results
For reasons of simplicity and lack of knowledge of the state of the charge in the binding sites of serum-transferrin near neutrality, the charges of the protein species involved are not given.
When two neutral solutions (7.00 4 pH 4 8.2) of apotransferrin and Fe(AHA) 3 containing bicarbonate are mixed rapidly, four kinetic phenomena are observed by¯uorescence emission detection and two by absorption detection (Figures 1 to 3) . The ®rst kinetic phenomenon occurs in the 100 ms to one second range, is detected by an exponential decrease in the¯uorescence intensity and leads to the accumulation of a ®rst kinetic product (Figure 1(a) ). Its rate depends on the analytical protein concentration (c 1 ), complex concentration (c 2 ), analytical AHA ligand concentration (c 3 ), bicarbonate concentration and pH. Under our experimental conditions, this process is not detected by absorption spectroscopy. In the second kinetic phenomenon, the ®rst kinetic intermediate yields a second kinetic product (Figures 1(b) -(d), 2 and 3). This is detected as an exponential increase in absorption with time in the 330 nm or 460 nm range (Figure 1(b) ) or a slight decrease of the¯uorescence emission intensity. The rate of this process depends only on pH and seems to be independent of c 1 , c 2 , c) to (e)). This process occcurs in the 100 second range. It is revealed by an exponential increase in absorption with time for 320 nm 4 l 4 380 nm and for l 5 480 nm or its decrease for 380 nm 4 l 4 470 nm (Figures 1(c) , (d) and 3). It is also detected as an exponential decrease in the emission¯uorescence intensity (Figure 1(e) ). Finally, the third kinetic intermediate gives the thermodynamic product (Figure 1(e) ). This last kinetic phenomenon is detected as an exponential decrease in the¯uorescence emission intensity with time (Figure 1(e) ). It is complete in about 4000 seconds and is independent of the concentrations of the species present in the medium. The¯uor-escence emission spectra measured after mixing apotransferrin with one equivalent or ®ve equivalents of Fe(AHA) 3 at the end of each kinetic process, and before the beginning of the following phenomenon, and those measured at the thermodynamic equilibrium (Figure 2 ) are identical to those measured after the mixing of apotransferrin with FeNAc 3 . However, the absorption spectra measured under the same conditions are very different from those reported with FeNAc 3 . Nevertheless, when serum-transferrin interacts with only one equivalent of Fe(AHA) 3 , the absorption spectrum of the ®rst kinetic intermediate at the end of second process (Figure 1(b) and (c)) is identical to that reported under the same conditions with FeNAc 3 (Figure 3 ; .
All results are reported at an ionic strength m 0.2. However, in order to test the salt or ionic strength effect on iron uptake (Williams et al., 1982; Aisen, 1998) some experiments were performed at ionic strengths varying from 0.1 to 0.5 with KCl concentrations varying from 50 to 400 mM. The results were identical to those obtained at m 0.2. Therefore, under our experimental conditions, the salt effect was not observed.
First kinetic process
As with iron uptake from FeNAc 3 , we will assume that the kinetic product accumulated at the end of the fast process shown in Figure 1 (a) only involves iron uptake by the C-site of the protein . At ®xed pH, c 1 and c 3 , with c 2 varying from 10c 1 to 100c 1 , there is a linear relationship between the experimental reciprocal relaxation times ((t 1 ) À1 ) related to this ®rst fast kinetic process shown in Figure 1 (a) and (c 2 À c 1 ). This relationship was also observed during iron uptake from FeNAc 3 by serum-transferrin, lactoferrin and ovotransferrin (Bou Abdallah & El Hage Chahine, 1998; Pakdaman et al., 1998) . Furthermore, at ®xed pH, c 1 and c 2 10c 1 , with c 3 varying from 5c 2 to 50c 2 , there is another linear relationship between experimental (t 1 )
À1
and 1/c 3 . This relationship was not observed during iron uptake from FeNAc 3 . Although under our experimental conditions (7.00 < pH < 8.2) (FeL 3 ) Fe(AHA) 3 , is the major acetohydroxamatoFe(III) species, it is in a fast equilibrium with the minor FeL 2 species which is in equilibrium with the very minor FeL species (equations (14) and (15); Martell & Smith, 1989; Schwarzenbach & Schwarzenbach, 1963; Monzyk & Crumbliss, 1979; Birus et al., 1985) . Furthermore, if FeL 3 was directly involved in the uptake of iron by serum-transferrin, there would not be a linear relationship between the experimental (t 1 )
À1 and 1/[L]. This linear relationship implies that FeL 2 is the species involved in this uptake. Indeed, if FeL were the species involved in the uptake of iron, a linear relationship between (t 1 )
À1 and 1/[L] 2 would be observed (Bernasconi, 1976) . These facts led us to envisage two possible mechanisms for the ®rst step of iron uptake by the C-site of serumtransferrin in interaction with bicarbonate (T C H 3 ) from Fe(AHA) 3 . In Mechanism III, an intermediate ternary complex is formed, whereas in Mechanism IV, this complex is not formed. As with FeNAc 3 , iron uptake from acetohydroxamatoFe(III) will be followed by proton loss ( .
The reciprocal relaxation time equations associated with equations (16) and (18) when each is rate-limiting can be expressed by equations (19) and (21), respectively (see the Appendix):
which under our experimental conditions (c 2 > 10c 1 and 0 4 c 3 4 50c 2 ) can be expressed as:
which can be expressed as: Bellounis et al., 1996) .
Equation (20) is not obeyed by the experimental data. Mechanism III is, therefore, discarded.
A very good linear least-squares regression of the experimental data against equation (22) is obtained (Figure 4) . From the slope of the best regression line k 1 4.15(AE0.05) Â 10 7 M À1 s À1 is determined with k À1 much too small to be measured. Transferrin, Mechanism of Iron Uptake
Second kinetic process
The rate of the second kinetic process shown in Figures 1(b) and (c) depends on nothing other than pH. This process is identical to that observed during serum-transferrin iron uptake from FeNAc 3 . We, therefore, ascribe it to equation (4) followed by acid-base equation (5). The reciprocal relaxation time associated with equation (4) is expressed as equation (23) :
which can be expressed as equation (24):
. A multi-linear least-squares regression of the experimental data against equation (23) shows that m > 1. Linear least-squares regressions of the data against equation (24) are satisfactory for m 2 and m 3; both gave k 2 3.25(AE0.15) s À1 ( Figure 5 ). This value is, within the limits of uncertainty, equal to that reported for serum-transferrin iron uptake from FeNAc 3 .
Third kinetic process
The absorption amplitude of the second kinetic process shown in Figure 1 (d) varies with l ( Figure 3) . Fe(AHA) 3 and AHA have typical absorption spectra in the wavelength range at which our experiments were performed (Figure 3) . The amplitude of a kinetic process is expressed as the sum of the contributions of the absorption variation of all the species involved (Dubois et al., 1992) . This explains the amplitude decrease at 330 nm 4 l 4 480 nm and its increase at l 5 480 nm. When c 1 % c 2 , Fe(AHA) 3 reacts completely with serum transferrin. In this case, the spectrum measured at the end of the second kinetic process and before the beginning of the third process (Figure 1(c) ) is that of FeT C H 5 . This absorption spectrum matches that reported by Cowart et al. (1982) under very low bicarbonate concentrations and similar conditions of concentrations (Figure 3) . The rates of these kinetic processes are identical to those reported for serum-transferrin iron uptake from FeNAc 3 . The experimental reciprocal relaxation times, (t 3 )
À1 , obey equation (25) which is associated with equation (6) when followed by acid-base equation (7) :
.8 nM .
A linear least-squares regression of the experimental¯uorescence data against equation (25) gave k 3 5.90(AE0.30) Â 10 À2 s À1 (Figure 6 ). This value is, within the limits of uncertainty, equal to that reported for serum-transferrin iron uptake from FeNAc 3 .
The fourth kinetic process
The fourth kinetic process is only observed bȳ uorescence and occurs in about 4000 seconds (Figure 1(d) ). Its reciprocal relaxation time is independent of the concentration of the species present in the medium. It therefore describes a ®rst-order kinetic process (Bernasconi, 1976) . This process is identical to that observed in the case of iron uptake by serum-transferrin in the presence of FeNAc 3 . Subsequently, it can be associated with equations (9) and (10).
Discussion
In Table 1 we summarise the mechanisms of serum-transferrin iron uptake from triacetohydroxamatoFe(III) and nitrilotriacetatoFe(III) . Under our experimental conditions, 7.00 4 pH 4 8.2, acetohydroxamatoFe(III) is mostly in the Fe(AHA) 3 form (Schwarzenbach & Schwarzenbach, 1963) . However, at pH 5 8 part of the chelate can be hydroxylated (Brown & Chidambararm, 1978) . This does not seem to affect our kinetic analysis, mostly because iron uptake by serum-transferrin occurs from the (18)).
The only difference between the two mechanisms of Table 1 lies in the ®rst step and in the fact that with Fe(AHA) 3 , the ®rst kinetic process is detected by¯uorescence emission and not by absorption. This explains why this step was not detected by Cowart et al., (1982) who used only absorption spectroscopy. Indeed, an analysis of the kinetics of serum-transferrin iron uptake from acetohydroxamatoFe(III) by stopped-¯ow with absorption detection only shows the existence of two kinetic processes (Figures 1(c) and (d) ) instead of the four detected by¯uorescence emission. The ®rst¯uorescence detected process (Figure 1(a) ) is fast. The direct second-order rate constant, k 1 , measured in the presence of Fe(AHA) 3 (Table 1 and equation (18)) is higher than that reported with FeNAc 3 (Table 1 and equation (2)). This, added to the fact that the reverse rate constant, k À1 , is too small to be measured, seems to imply that the af®nity of (T C H 3 ), the C-site of serum-transferrin in interaction with bicarbonate (k 1 /k À1 ), for Fe(AHA) 2 is higher than for FeNAc 3 . With both chelators this step is fast and occurs without the accumulation of any ternary chelate-protein intermediate. It, nevertheless, leads to the accumulation of a ®rst kinetic intermediate (Figure 1(a) ) and is followed by a single proton loss (Table 1 and equations (2), (18) and (3)). This kinetic product is responsible for all the subsequent processes, which lead to the accumulation of two other kinetic products and, ®nally, to the C-site iron-loaded and/or the holo-protein (Table 1 and equations (4) to (10)). This mechanism was reported for the three major proteins of the transferrin family serum-transferrin, lactoferrin and ovotransferrin (Bou Abdallah & El Hage Chahine, 1998; Pakdaman et al., 1998) .
The ®rst kinetic step detected by absorption spectroscopy by us and by Cowart et al., (1982) corresponds to the second kinetic process detected bȳ uorescence spectroscopy. This step leads to the accumulation of a kinetic product (Figure 1(c) and (d)), which was assumed by Cowart et al. (1982) to be the ternary transferrin-acetohydroxamatoFe(III) intermediate complex. We show that this second kinetic intermediate (Figure 1(b) ) cannot be ascribed to a ternary intermediate complex between the protein and the chelate. The¯uor-escence emission spectrum of this intermediate is that of kinetic product TH 5 Fe (Figure 2(b) ). It is formed with the same elementary rate constant whether Fe(III) uptake occurs from FeNAc 3 or Fe(AHA) 3 (Table 1, equations (4), (23) and (24) Transferrin, Mechanism of Iron Uptake followed by the loss of two or three protons (Table 1 and equations (4) and (5)). The third kinetic process detected by¯uor-escence is identical to the second process detected by absorption for serum-transferrin iron uptake from Fe(AHA) 3 (Figure 1(c) and (d)). This process was ascribed by Cowart et al. (1982) (Figure 2(b) and (d) ). This process is identical to that observed with the uptake of iron by serum-transferrin, as indicated by the identical formation rate constant, k 3 (Table 1 and equations (6) to (8)). It is followed by a proton loss and ratelimits Fe(III) uptake by the N-site of the protein (Table 1 and equation (7)). As for the fourth kinetic processes, they were only detected by¯uorescence spectroscopy; they last about 4000 seconds and are strictly identical to those observed during iron uptake from FeNAc 3 . They were not reported by Cowart et al. (1982) . We ascribe them to a last modi®cation in the conformation of the C-site monoferric or diferric iron-loaded serum-transferrin during which the iron-loaded species attain their ®nal state of equilibrium as holo-or monoferric proteins.
We were able to sequentially detect the four kinetic processes involved in the uptake of iron by transferrin because, in the cases of Fe(AHA) 3 and FeNAc 3 the ®rst kinetic steps always described the uptake of iron by the C-site of the protein in interaction with bicarbonate. However, if these Fe(III) uptakes were slower than the last modi®cations in the conformation of the metal-loaded protein (Table 1 and equations (9) and (10)), they can become rate limiting and only one step would be observed for the uptake of iron. This is probably the case with some chelates such as the ferric citrate where the uptake of iron by serum-transferrin lasts several hours and where the ®rst step in the uptake is that of the depolymerisation of the iron citrate chelate (Bates et al., 1967) . We, therefore, believe that in vitro iron uptake by serumtransferrin occurs by the same mechanism regardless of the nature of the iron-providing chelate. Only the differences in the rates of the uptake would be due to the nature of the chelate. Does all this imply the formation of the ternary intermediate protein-metal-chelator complex, as shown during iron loss in mildly acidic media from a decarbonated protein in a different state of conformation and protonation than the holoprotein in neutral media (El Hage Chahine & Pakdaman, 1995) and suggested in neutral media (Bates et al., 1967; Bates & Schlabach, 1975; Cowart et al.,1982 Cowart et al., , 1986 Egan et al., 1992) ? This question cannot be answered directly at this stage. Indeed, although when absorption detection is used, our experimental signals are similar to those reported by Cowart et al. (1982) , our conclusions differ markedly from theirs. We cannot, however, neglect the involvement of a ternary complex in iron uptake by transferrins. Our results only imply that this intermediate, if it exists, does not accumulate as a kinetic product (Bou Abdallah & El Hage Chahine, 1998; Pakdaman et al., 1998) .
In neutral media, transferrins transit from a both lobes opened apo conformation, to a C-lobe closed and an N-lobe opened in the monoferric C-site iron-loaded protein and to ®nally the holoprotein in which both lobes are in a closed conformation (Moore et al., 1997; Jeffrey et al., 1998; Zuccola, 1992) . In both lobes, iron is co-ordinated to two phenolates of two tyrosine residues, to one imidazol of a histidine residue, to a carboxylate of an aspartate residue and to a synergistic carbonate (Moore et al., 1997; Jeffrey et al., 1998; Zuccola, 1992) . In the opened conformation of the apo form, .
these ligands are in contact with the bulk aqueous medium. The C-site of the apo form is, moreover, in interaction with hydrogen-carbonate and not carbonate (Bellounis et al., 1996; Pakdaman & El Hage Chahine, 1997; Bou Abdallah & El Hage Chahine, 1998) . Furthermore in the opened apo form, the acid-base pK a value of the protein ligands, specially the two phenols, should be close to those in aqueous media (about 10), and would be, subsequently, protonated (El Hage Chahine & Pakdaman, 1995; El Hage Chahine & Fain, 1993 , 1994 Russel et al., 1987) . When in the vicinity of pH 7 the protein interacts with iron, its structure shifts from the opened apo con®guration to the closed holo con®guration in which the protein ligands and the synergistic anion are in the deprotonated form (Moore et al., 1997; Jeffrey et al., 1998; Zuccola, 1992) . This occurs in the four kinetic steps shown in Figure 1 and as described in Table 1 . The environment of the protein ligands and the bicarbonate are, consequently, considerably altered by chelation and by water expulsion from the binding cleft (El Hage Chahine & Fain, 1993 , 1994 Bou Abdallah & El Hage Chahine, 1998; Russel et al., 1987; Hancock & Martell, 1989 ). This process is well illustrated in the absence of bicarbonate. Indeed, when NAc 3 is the only synergistic anion present in the medium, serum-transferrin interacts with FeNAc 3 to form a mixed FeNAc 3 -transferrin complex in which NAc 3 can be readily replaced by carbonate upon addition of bicarbonate (El Hage Chahine & Fain, 1993; . A deprotonation pK a value of 6.34 was reported during the ®rst step of FeNAc 3 uptake by serum-transferrin in the absence of bicarbonate and was ascribed to that of the phenols of the tyrosine engaged in the mixed complex formation (El Hage Chahine & Fain, 1993) . Addition of bicarbonate leads to two other deprotonations detected (average pK a 7.2) upon the substitution of NAc 3 by carbonate in the mixed FeNAc 3 -transferrin complex to yield the holoprotein . We can, therefore, ascribe the proton transfers which follow the modi®cations in conformation during the uptake of iron by serumtransferrin (equations (3), (5) and (7)) to the deprotonation of bicarbonate and the phenols of the tyrosine residues engaged in complex formation. Because a protonated ligand, such as phenol or hydrogen carbonate, lacks af®nity for Fe(III) (Eigen & Wilkins, 1965; Wilkins, 1976; Hancock & Martell, 1989) , the ®rst fast step would involve the interaction of the metal with the available non-protonated carboxylate of aspartate and or imidazol of histidine. This is followed by the loss of a single proton probably provided by bicarbonate (equation (3)). The two domains of the C-lobe would then start enveloping iron, this being accompanied by the loss of two protons from the remaining phenols (equation (5)). The third proton-loss (equation (7)) may be provided by one of the side-chains of the ligands involved in the interdomain H-bonding network (Moore et al.,
1997; Kurokawa et al., 1995) . These ®rst three steps allow the protein to attain a conformation in which the N-site extracts iron from the chelate by a mechanism similar to that reported for the C-site Bou Abdallah & El Hage Chahine, 1998) . The iron-loaded serumtransferrin reaches afterward its ®nal equilibrated state in a last step during which all the interlobe interactions occur stabilising further the closed holo structure (Table 1 and equations (9) and (10)). This last step is two-to threefold slower with the scavenging agents lactoferrin and ovotransferrin (Bou Abdallah & El Hage Chahine, 1998) . It, therefore, rate-limits iron loss from the protein to a competing ligand or a siderophore. This is con®rmed by most of the results from the literature, where iron loss to a competing chelating agent in neutral media is slower with the iron scavenger lactoferrin than with the iron deliverer serum-transferrin (Egan et al., 1992; Chung & Raymond, 1993) . This may imply that the metabolic function of transferrins in iron scavenging and/or delivery is related to the kinetics of this last process.
Conclusion
In vitro, iron uptake by serum-transferrin from a chelate occurs without the accumulation of a kinetic ternary protein-chelate product. The nature of the iron-providing chelate does not seem to affect this thermodynamic equilibrium. It may, however, modify the kinetics by slowing the ®rst step to such an extent that it becomes rate limiting.
Materials and Methods
Better than 98 % pure human serum apotransferrin (Sigma, lot 47H9318) was further puri®ed and purity checked by published procedures (El Hage Chahine & Fain, 1993) . KCl (Merck Suprapur), NaOH, and HCl (Merck Titrisol), EDTA (Merck Titriplex), FeCl 3 , acetic acid and sodium carbonate (Merck), nitrilotriacetic acid (N(AcH) 3 ), and Hepes (Aldrich), glycerol, acetohydroxamic acid (H(AHA)), urea and boric acid (Sigma), acrylamide, bromophenol blue, Coomassie blue and TEMED (Boehringer Mannheim) were used without further puri®cation. Water and glassware were prepared as described (El Hage Chahine & Fain, 1993) .
Stock solutions
All stock solutions were used fresh. They were prepared in previously boiled bidistilled water. The Hepes concentration in neutral buffers was 50 mM and ®nal pH values were adjusted to between pH 7 and 8 with microquantities of concentrated HCl or NaOH. Transferrin concentrations (c 1 ) were checked spectrophotometrically (El Hage Chahine & Fain, 1993) . They ranged from 0.5 mM to 0.13 mM. Fe(AHA) 3 solutions (5 mM) were prepared by mixing three parts of a neutral solution of acetohydroxamic acid with one part of an equimolar solution of FeCl 3 at pH 2. The pH was slowly raised to pH 6 with microquantities of 10 M NaOH. These solutions were further diluted to the required ®nal Fe(AHA) 3 concentrations in the buffers. The NaHCO 3 concentrations Transferrin, Mechanism of Iron Uptake ranged from 5 mM to 30 mM in the apotransferrin and Fe(AHA) 3 solutions. All ®nal ionic strengths were adjusted to 0.2 M with KCl.
Iron-loaded transferrins
The holoprotein was obtained in the presence of 20 mM bicarbonate when apotransferrin was allowed to interact for several hours with more than two equivalences of Fe(AHA) 3 or FeNAc 3 . The only C-site ironloaded serum transferrin was obtained under similar conditions when the protein interacted with only one equivalemt of Fe(AHA) 3 or FeNAc 3 . This iron load was always checked by polyacrylamide/urea gel electrophoresis (El Hage Chahine & Pakdaman, 1995; Makey & Seal, 1976) .
Spectrophotometric measurements
Absorption measurements were performed at 25(AE0.1) C on a Perkin Elmer Lambda 2 spectrophotometer equipped with a magnetic stirring device and thermostatted cell carrier. Fluorimetric measurements were performed at 25(AE0.1) C on a Aminco-Bowman series 2 luminescence spectrometer equipped with a thermostatted cell carrier. Emission spectra were measured in the 300 nm to 420 nm range. The excitation wavelength was set to 280 nm (Lehrer, 1969; .
Stopped-flow measurements
Fast kinetic measurements were performed on an SF 3L Hi-Tech stopped-¯ow spectrophotometer equipped with two different light sources and a thermostatted bath at 25(AE0.5) C, as described (Bou Abdallah & El Hage Chahine, 1999).
Mathematical formalism and signal analysis
The experimental conditions were set so as to permit the use of chemical relaxation formalism; all experimental signals were analysed as described elsewhere (El Hage Chahine & Fain, 1993; FeT C H 2 ÁH aK 1a 37
From equations (30), (32) and (33) to (37), equation (21) is derived.
